Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 187

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

An assessment by the Statin Liver Safety Task Force: 2014 update

Bays, Harold, Cohen, David E., Chalasani, Naga, Harrison, Stephen A. · 2014 · Journal of Clinical Lipidology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacl.2014.02.011

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 14

  1. James, 2014, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members Appointed to the Eighth Joint National Committee (JNC 8), JAMA, 311, 507, 10.1001/jama.2013.284427 · DOI · Paper page
  2. Stein, 2011, Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia, Circulation, 123, 1974, 10.1161/CIRCULATIONAHA.110.975284 · DOI
  3. Cohen, 2006, An assessment of statin safety by hepatologists, Am J Cardiol, 97, 77C, 10.1016/j.amjcard.2005.12.014 · DOI · Paper page
  4. Torres, 2012, Features, diagnosis, and treatment of nonalcoholic fatty liver disease, Clin Gastroenterol Hepatol, 10, 837, 10.1016/j.cgh.2012.03.011 · DOI · Paper page
  5. Chatrath, 2012, Dyslipidemia in patients with nonalcoholic fatty liver disease, Semin Liver Dis, 32, 22, 10.1055/s-0032-1306423 · DOI · Paper page
  6. Athyros, 2010, Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis, Lancet, 376, 1916, 10.1016/S0140-6736(10)61272-X · DOI · Paper page
  7. Ekstedt, 2007, Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study, J Hepatol, 47, 135, 10.1016/j.jhep.2007.02.013 · DOI · Paper page
  8. Nelson, 2009, A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: a randomized placebo-controlled trial, J Clin Gastroenterol, 43, 990, 10.1097/MCG.0b013e31819c392e · DOI · Paper page
  9. Alla, 2006, Autoimmune hepatitis triggered by statins, J Clin Gastroenterol, 40, 757, 10.1097/00004836-200609000-00018 · DOI
  10. Russo, 2009, Drug-induced liver injury associated with statins, Semin Liver Dis, 29, 412, 10.1055/s-0029-1240010 · DOI · Paper page
  11. John, 2013, Statins as a Potential risk factor for autoimmune diseases: a case report and review [e-pub ahead of print], Am J Ther, 10.1097/MJT.0b013e31828e5bfb · doi:10.1097/mjt.0b013e31828e5bfb
  12. Lardizabal, 2010, Benefits of statin therapy and compliance in high risk cardiovascular patients, Vasc Health Risk Manag, 6, 843
  13. Davern, 2011, Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury, Gastroenterology, 141, 1665, 10.1053/j.gastro.2011.07.051 · DOI · Paper page
  14. D'Agata, 1999, Evaluation of liver disease in the pediatric patient, Pediatr Rev, 20, 376, 10.1542/pir.20-11-376 · doi:10.1542/pir.20-11-376

Cited by

See all 187

Metadata

Authors
Bays, H., Cohen, D. E., Chalasani, N., & Harrison, S. A.
Venue
Journal of Clinical Lipidology
Publisher
Elsevier BV
Published
2014-05
Volume
8
Issue
3
Pages
S47-S57
ISSN
1933-2874
Cited by
187
References
7
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An assessment by the Statin Liver Safety Task Force: 2014 update. https://app.cochat.ai/papers/10.1016/j.jacl.2014.02.011
The paper
Bays, H., Cohen, D. E., Chalasani, N., & Harrison, S. A. (2014). An assessment by the Statin Liver Safety Task Force: 2014 update. Journal of Clinical Lipidology. https://doi.org/10.1016/j.jacl.2014.02.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.